Morning Traders Alert: Tilray Brands, Inc. (NASDAQ:TLRY 1.08%), Alteryx, Inc. (NYSE:AYX 13.78%) 2023/02/10 16:29:13 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Traders Alert: Tilray Brands, Inc. (NASDAQ:TLRY 1.08%), Alteryx, Inc. (NYSE:AYX 13.78%) appeared first on Stocks Equity .
Tilray Vs. Canopy Growth: Which Cannabis Stock Is The Better Buy? 2023/02/10 14:15:04 Seeking Alpha
Tilray and Canopy Growth recently released earnings that showed the continued headwinds faced by legal Cannabis operators in Canada. See which stock is a buy.
Why Tilray (TLRY) Shares Are Falling 2023/02/09 19:22:17 Benzinga
Tilray Inc (NASDAQ: TLRY ) shares are trading lower by 4.46% to $2.90 during Thursday''s session. Shares are trading lower in sympathy with peer cannabis company Canopy Growth Corporation (NASDAQ: CGC ), which released its financial results for the third quarter, revealing net revenue of CA$101 million ($75.4 million), down 28% year over year. Tilray traders and investors may also … Full story available on Benzinga.com
Teeter-tottering stocks: Tilray Brands, Inc. (NASDAQ:TLRY -3.50%), Medical Properties Trust, Inc. (NYSE:MPW -0.08%) 2023/02/09 05:00:58 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Teeter-tottering stocks: Tilray Brands, Inc. (NASDAQ:TLRY -3.50%), Medical Properties Trust, Inc. (NYSE:MPW -0.08%) appeared first on Stocks Equity .
Cannabis Products Global Market Report 2023 2023/02/08 17:23:00 GlobeNewswire
Major players in the cannabis products market are Canopy Growth Corporation, Aphria Inc, Aurora Cannabis, Cara Therapeutics, GW Pharmaceuticals PLC, Maricann Group, Tilray, The Cronos Group, Tikun Olam and United Cannabis Corporation. Major players in the cannabis products market are Canopy Growth Corporation, Aphria Inc, Aurora Cannabis, Cara Therapeutics, GW Pharmaceuticals PLC, Maricann Group, Tilray, The Cronos Group, Tikun Olam and United Cannabis Corporation.
Inflation Fears Bring Markets Sharply Down 2022/12/05 21:26:00 Baystreet Canada
Fear gripped investors in Toronto Monday, with apprehension over the Bank of Canada’s rate move this week and whether it alone will be sufficient to stop inflation. The TSX Composite toppled 243.4 points, or 1.2%, to end Monday at 20,242.26. The Canadian dollar fell 0.81 cents to 73.55 cents U.S. Tech stocks took the worst bath, with HUT 8 Mining tailing off 13 cents, or 7.8%, to $1.54, while BlackBerry chucked 42 cents, or 6%, to $6.58. Among energy concerns, Crescent Point Energy faltered 41 cents, or 4%, to $9.84, while Enerplus dipped $1.03, or 4.2%, to $23.41. Gold also lost luster, as OceanaGold gave back 18 cents, or 6.8%, to $2.48, while Wesdome Gold lost 60 cents, or 6.7%, to $8.37. Utilities tried to limit the damage, as AltaGas surged 95 cents, or 4.2%, to $23.77, while Northland Power collected 51 cents, or 1.4%, to $38.19. In communications, TELUS climbed 47 cents, or 1.6%, to $29.07, while Rogers jumped 76 cents, or 1.2%, to $63.00. In health-care, Tilray gained 16 cents, or 2.6%, to $6.31, while Cronos Group pointed up nine cents, or 1.9%, to $4.76.
Why Tilray and Other Pot Stocks Jumped Early Monday 2022/12/05 20:44:26 The Motley Fool
Canadian marijuana companies have plenty to gain if banking reform passes.
Why Cannabis Stocks TLRY, CGC, SNDL Are Heating Up Today 2022/12/05 18:36:23 InvestorPlace
Source: gvictoria / Shutterstock.com Cannabis stocks are in the news Monday as investors hold out hope for lawmakers to push through new marijuana laws. The latest reports claim that a group of senators intend to attach new policies surrounding marijuana to bills that need to pass by the end of the year. This could pave the way for new marijuana laws on a federal level. Interest in passing new marijuana laws is a bipartisan one. Senators on both sides of the aisle support the changes that could come. Among those are granting cannabis companies access to banking institutions, as well as grants for states expunging criminals with prior marijuana convictions. If these new marijuana rules become law, it could mark a major win for cannabis stocks . It would also put them one step closer to the legalization of the drug on a federal level. Let’s see how that’s affecting pot stocks below! Cannabis Stocks Up on Monday Tilray (NASDAQ: TLRY ) stock starts out list with the cannabis company’s shares climbing 5.6% higher as of Monday afternoon.
TLRY stock, SNDL stock lead cannabis stocks higher as Biden signs marijuana research bill 2022/12/02 20:30:38 Seeking Alpha
Cannabis stocks extended recent gains to rally towards the market close on Friday after President Joe Biden signed a marijuana research bill into law.Notable gainers include Clever…
Thinking about buying stock in Rigel Pharmaceuticals, Mullen Automotive, COMSovereign, Credit Suisse, or Tilray? 2022/12/02 15:44:00 Kwhen Finance
Stocks Slumber to End Week 2022/06/03 20:23:00 Baystreet Canada
Equities in Canada’s largest centre endured a sharply negative end to a wild week, as lower prices for health-care and tech issues cast a pall over the indexes. The S&P/TSX lost 241.08 points, or 1.2%, to close Friday and the week at 20,790.73. Over the last five session, the index moved forward, however, 42 points, or 0.2%. The Canadian dollar dipped 0.13 cents to 79.42 cents U.S. Tech stocks provided the heaviest weight on the market, with Shopify plunging $59.97, or 12%, to $441.17, while Magnet Forensics stumbled $1.03, or 6.3%, to $15.46. Cannabis concerns proved the main agent of the demise, as Canopy Growth flopped 49 cents, or 8,3%, to $5.43, while rival Tilray faltered 29 cents, or 8.3%, to $5.29. In consumer discretionary stocks, BRP lost $10.79, or 10.7%, to $89.79, while Martinrea International subsided 81 cents, or 7.9%, to $9.45. Consumer staples tried to even things out, with Loblaw jumping $1.98, or 1.7%, to $117.66, while Metro advanced 78 cents, or 1.1%, to $71.59. Energy stocks also muscled up, with Baytex taking on 53 cents, or 7.6%, to $7.63, while Tamarack Valley gained 27 cents, or 5.1%, to $5.62.
TSX Steps Back from Thursday Gains 2022/06/03 16:16:00 Baystreet Canada
Stocks in Canada’s main market were driven lower on Friday as upbeat U.S. jobs data deepened concerns of more interest rate hikes. The S&P/TSX had lost 216.74 points, or 1%, by noon to 20,815.07. The Canadian dollar dipped 0.03 cents to 79.52 cents U.S. Cannabis concerns proved the main agent of the demise, as Canopy Growth flopped 41 cents, or 6.9%, to $5.51, while rival Tilray faltered 30 cents, or 5.4%, to $5.28. In tech stocks, Docebo fell $2.74, or 6.3%, to $40.81, while Shopify stumbled $45.48, or 9.1%, to $455.66. In gold stocks, Alamos Gold dulled in price 51 cents, or 4.8%, to $10.09, while IAMGOLD Corporation demurred 12 cents, or 4%, to $2.90. ON BAYSTREET The TSX Venture Exchange lurched lower 8.51 points, or 1.2%, to 719.96. All 12 TSX subgroups were down midday, as health-care subsided 3.3%, information technology slouched 3.1%, and gold dropped 2.2%. ON WALLSTREET U.S. stocks slid Friday as investors digested a stronger-than-expected jobs report and its implication for monetary policy going forward.
Flora Growth Follows Tilray: Reaches Amazon UK With Its Cannabis Brand JustCBD 2022/05/31 12:24:25 Benzinga
JustCBD wholly-owned subsidiary of Flora Growth Corp. (NASDAQ: FLGC ) will be launching its line of n ovel f oods registered CBD products on Amazon.co.uk. The news comes on the heels of Canadian cannabis giant, Tilray (NASDAQ: TLRY ) rolling out its CBD lifestyle brand with a new approach to wellness, POLLEN, on the same online retail platform. Amazon UK (NASDAQ: AMZN ) entered the now £700 million CBD market in October 2021 and has since expanded the initial pilot-only program to include vendors who have demonstrated their … Full story available on Benzinga.com
Want to Invest in Pot Stocks? Buy Tilray, Not HEXO 2022/05/30 11:09:43 InvestorPlace
Source: Shutterstock Cannabis stocks have experienced significant growth in the past few months. However, this trend came to an end in the last few weeks when the stocks of many cannabis companies started to plummet. Unfortunately, HEXO (NASDAQ: HEXO ) stock is not an exception in this regard. Following a string of unfortunate events, the Canadian cannabis producer is in rough shape. The past year has been tough for them, not least because of the audit firm PricewaterhouseCoopers warning that the company’s debt situation is raising concerns about its “going concern” status. After a long string of bad luck and setbacks, the company recently found a new opportunity. Tilray (NASDAQ: TLRY ) expressed interest in purchasing some of their debt to help save the company — even though everyone is still on edge about how the buyout will affect them. In March, Tilray agreed to purchase up to $211 million in HEXO’s debt, giving Tilray the right to buy a significant portion of HEXO. HEXO has been facing financial turmoil, so the new deal helped perk up investor sentiment.
Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint 2022/05/27 14:17:44 InvestorPlace
Source: Jetacom Autofocus / Shutterstock.com Many cannabis stocks are declining today after one of the largest companies in the sector, Canopy Growth (NASDAQ: CGC ), reported fiscal fourth-quarter results that were significantly below analysts’ average estimates. CGC stock is tumbling 15% in early trading. Meanwhile, another cannabis company, Aurora (NASDAQ: ACB ), announced that it would raise $150 million by selling stock and warrants. That news also seems to be putting downward pressure on cannabis stocks. Canopy’s Q4 Results The company’s Q4 revenue dropped 25% to 111.8 million CAD, well below analysts’ average estimate of 130.5 million CAD. The cannabis maker reported a per share loss of 1.46 Canadian dollars. That is also much wider than estimates for a loss of 21 cents CAD. Canopy CFO Judy Hong said: “Achieving profitability is critical and we have undertaken additional initiatives to streamline and drive efficiencies for our global cannabis business. … [W]e are focused on executing our path to profitability in Canada, while we continue to invest in high potential opportunities.” The company added that it would seek to grow its business in the U.S.